Bizarre Patents
Mountable Printable Placard With Headband
A resilient headband in a shape for being mounted on the head of the user. The headband is equipped with a longitudinal slotted member for holding a placard.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8178537 | Solid state forms of varenicline salts and processes for preparation thereof Salts and crystalline forms of several salts of Varenicline, i.e., Varenicline sulfate: are provided, along with methods of preparing the solid states and processes for preparing Varenicline base from those Varenicline salt... | 05/15/2012 |
| 8173657 | Imidazoquinoxaline compounds as immunomodulators The invention provides novel compositions comprising imidazoquinoxaline compounds of formula (I) and analogs thereof. Also provided are methods of administering the compositions in an effective amount to enhance the immune response of a subject. Further provided are... | 05/08/2012 |
| 8163752 | Tricyclic anilide heterocyclic CGRP receptor antagonists Compounds of formula I: wherein variables A1, A2, B, m, n, J, R4, G1, G2, G3 and Y are as described herein, which are antagonists of CGRP receptors and which... | 04/24/2012 |
| 8148377 | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile Pharmaceutical compositions containing dihydroergotamine (DHE) and methods in which DHE is administered to patients for treatment of migraine without side effects or adverse effects are disclosed. Methods for rapid treatment of migraine with DHE are disclosed compri... | 04/03/2012 |
| 8143255 | Heteroalkyl linked pyrimidine derivatives The present invention relates to pyrimidine compounds that are useful as anti-proliferative agents. More particularly, the present invention relates to heteroalkyl linked and substituted pyrimidine compounds, methods for their preparation, pharmaceutical composition... | 03/27/2012 |
| 8133891 | Tricyclic anilide spirolactam CGRP receptor antagonists The present invention is directed to compounds of Formula I: I (where A1, A2, B1, B2, B3, B4, D1, D2, J, K, T, U, V, W, X, Y, Z, R4, R5a, R5b, R | 03/13/2012 |
| 8129387 | Substituted 5,6-dihydroimidazo[1,5-F]pteridines useful as protein kinase inhibitors The present invention relates to substituted 5,6-dihydroimidazo[1,5-f]pteridines of formula I: which are useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprisin... | 03/06/2012 |
| 8129386 | Fused azole-pyrimidine derivatives The present invention relates to novel fused azolepyrimidine derivatives, processes for preparing them and pharmaceutical preparations containing them. The fused azolepyrimidine derivatives of the present invention exhibit enhanced potency for phosphotidylinositol-3... | 03/06/2012 |
| 8129385 | Substituted 5-hydroxy-3,4,6,9,9a, 10-hexanhydro-2h-1-oxa04a,8a-diaza-anthracene-6,10-dioness The present invention is directed to a class of substituted 5-hydroxy-3,4,6,9,9a,10-hexahydro-2H-1-oxa-4a,8a-diaza-anthracene-6,10-diones useful as anti-HIV agents. The compounds have the formula: Z═O; R20, R | 03/06/2012 |
| 8124606 | Substituted 7,8,9,10-tetrahydro-5H-dipyrido[1,2-a:3′,2′-e]pyrazin-6(6aH)-ones Disclosed are compounds of the following formula: in which R1, R2, R5, R6, R7, R11, X, and m are defined in the specification. Also disclosed are pharmaceuti... | 02/28/2012 |
| 8119640 | Hedgehog pathway antagonists methods of use The present disclosure provides for compounds, pharmaceutical preparations, kits and methods for the inhibition of the Hh pathway and the alleviation of cancer and developmental disorders associated with the Hh pathway. ... | 02/21/2012 |
| 8119638 | Compositions and uses of ET743 for treating cancer Et 743 is used in the preparation of a medicament for the treatment of the human body for cancer. ... | 02/21/2012 |
| 8119639 | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile Pharmaceutical compositions containing dihydroergotamine (DHE) and methods in which DHE is administered to patients for treatment of migraine without side effects or adverse effects are disclosed. Methods for rapid treatment of migraine with DHE are disclosed compri... | 02/21/2012 |
| 8097628 | Compounds Compounds of Formula (I) or pharmaceutically acceptable salts or N-oxides thereof: (relative chemistry shown) pharmaceutical compositions comprising them, their use in therapy especially against tuberculosis, and methods of... | 01/17/2012 |
| 8084453 | Alkyl substituted indoloquinoxalines Novel substituted indoloquinoxalines of formula (I wherein R1 is hydrogen or represents one or more similar or different substituents in the positions 7 to 10 selected from the ... | 12/27/2011 |
| 8076337 | Antitumoral derivatives of ET-743 Derivatives of Et-743 or Et-770 or Et-729 are provided. The derivatives are of the general formula Ia.: wherein the substituent groups take various permitted meanings. ... | 12/13/2011 |
| 8067417 | Imidazo[1,2-F]pteridines useful as inhibitors of protein kinases The present invention relates to compounds useful as inhibitors of protein kinase, represented by Structural Formula (I): wherein the variables in Structural Formula (I) are as described herein. The invention also provides ... | 11/29/2011 |
| 8058275 | Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting PARP The present invention relates to diazabenzo[de]anthracen-3-one compounds which inhibit poly(ADP-ribose) polymerase (“PARP”), compositions containing these compounds and methods for using these PARP inhibitors to treat, prevent and/or ameliorate the effects of th... | 11/15/2011 |
| 8026217 | Compositions and methods for treating neural anoxia and spreading depression Compositions and methods for protecting neural tissue (e.g., neurons) from anoxia and spreading depression (SD) involve inhibiting the cGMP-dependent protein kinase (PKG) pathway. It was discovered that the PKG pathway plays a crucial role in regulating SD and toler... | 09/27/2011 |
| 8012975 | Antitumoral analogs of ET-743 Antitumor compounds have the five membered fused ring ecteinascidin structure of the formula (XIV). The present compounds lack a 1,4-bridging group as found in the ecteinascidins. They have at the C-1 position a substituent selected from an optionally protected or d... | 09/06/2011 |
| 8012976 | Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) A compound having the structure set forth in Formula (I) and Formula (II): wherein the substituents Y, Z, A, B, R1, R2, R3, R4 and R5 are as defined herein. Provided he... | 09/06/2011 |
| 8003648 | Heterocyclic GPR40 modulators The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I: where the definitions of the variables are provided herein. The present... | 08/23/2011 |
| 7973040 | Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors The present invention relates to macrocyclic a compound of formula (I) and its use as inhibitors of the hepatitis C virus (HCV) NS3 protease, and in treating or preventing HCV infections. ... | 07/05/2011 |
| 7947682 | Substituted N′-pyrrolo[1,2-a]quinoxalin-4-yl-hydrazides as anti-cancer agents Novel compounds for treatment of cancer and disorders associated with angiogenesis function. Such compounds include a compound of Formula II, wherein R is H, alkyl, or h... | 05/24/2011 |
| 7928105 | Substituted 6a,7,8,9-tetrahydropyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-ones Disclosed are compounds of the following formula: in which R1, R2, R5, R6, R7, R31, u, and X are defined in the specification. Also ... | 04/19/2011 |
| 7919493 | Anititumoral ecteinascidin derivatives This invention relates to antitumoral ecteinascidin derivatives that contain a fused ecteinascidin five ring system with a 1,4-bridge having the structure of formula (VIa) or (VIb) as described herein and compounds in which the —NH2 or —OH of the 1,4-... | 04/05/2011 |
| 7884104 | Aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes The present invention is directed to novel substituted aminopiperidines which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DPP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme i... | 02/08/2011 |
| 7863274 | Deuterium enriched analogues of tadalafil as PDE5 inhibitors The present invention relates to derivatives of tadalafil represented by the formula: or a salt thereof, wherein: X1 and X2 are simultaneously fluoro; or X1 | 01/04/2011 |
| 7863275 | Uses of tetrahydrobiopterin and derivatives thereof The present invention discloses methods of treating diabetic gastroparesis by administering tetrahydrobiopterin or a derivative thereof. ... | 01/04/2011 |
| 7820668 | Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting PARP The present invention relates to diazabenzo[de]anthracen-3-one compounds which inhibit poly(ADP-ribose) polymerase (“PARP”), compositions containing these compounds and methods for using these PARP inhibitors to treat, prevent and/or ameliorate the effects of th... | 10/26/2010 |
| 7820667 | Methods of treating hypertension It is an object of the present invention to provide a therapeutic agent for effectively preventing or ameliorating diseases caused by dysfunction of NOS. The present invention provides a pharmaceutical composition for preventing and/or treating diseases assoc... | 10/26/2010 |
| 7816356 | Aryl and heteroaryltetrahydrocyclobutapyrroles as nicotinic acetylcholine receptor ligands Disclosed herein are compounds that bind to a neuronal nicotinic acetylcholine receptor. These compounds posses broad therapeutic use including the treatment of senile dementia, Alzheimer's disease, Parkinson's disease, attention deficit disorder, and the treatment ... | 10/19/2010 |
| 7799785 | Substituted tetracyclic tetahydrofuran, pyrrolidine and tetrahydrothiophene derivatives This invention concerns novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives with binding affinities towards serotonin receptors, in particular 5-HT2A and 5-HT2C receptors, and towards dopamine receptor... | 09/21/2010 |
| 7795260 | Synthesis of naturally occurring ecteinascidins and related compounds Ecteinascidin compounds with a quinone ring for ring E are active as anti-cancer agents. Related processes and compounds are provided. ... | 09/14/2010 |
| RE41614 | Synthetic analogs of ecteinascidin-743 The present invention is directed to the synthesis and characterization of compounds having the formula: wherein R1, R2, R3, R4, R5, R6, R... | 08/31/2010 |
| 7750010 | Tricyclic anilide spirohydantion CGRP receptor antagonists The present invention is directed to compounds of Formula I: I (where A1, A2, B1, B2, B3, B4, D1, D2, T, U, V, W, X, Y, Z, R4, R5a?, R5b, R5... | 07/06/2010 |
| 7709483 | Pyrrolo-quinoxalinone derivatives as antibacterials Tricyclic nitrogen containing compounds and their use as antibacterials. ... | 05/04/2010 |
| 7691859 | Prenyl transferase inhibitors A family of imidazole compounds useful for inhibiting the activity of prenyl transferases. The compounds are covered by the following formula: wherein X is (CHR11)n3(CH2)n4Z(CH | 04/06/2010 |
| 7674793 | Tricyclic dihydropyrazines as potassium channel openers The present invention is directed to novel tricyclic dihydropyrazine derivatives of Formula (I), pharmaceutical compositions containing them and their use in the treatment of disorders related to potassium channel. ... | 03/09/2010 |
| 7655654 | Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles This invention comprises the novel compounds of formula (I) wherein r, s, t, R1, R2, R3, R4, R5, and R6 have defined meanings, having farnesyl transferase in... | 02/02/2010 |
